🇺🇸 FDA
Patent

US 8828996

Morpholine-spirocyclic piperidine amides as modulators of ion channels

granted A61PA61P1/00A61P1/02

Quick answer

US patent 8828996 (Morpholine-spirocyclic piperidine amides as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
79
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16